Minocycline Development for Acute Ischemic Stroke
- 13 April 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Translational Stroke Research
- Vol. 2 (2), 202-208
- https://doi.org/10.1007/s12975-011-0072-6
Abstract
Minocycline, a tetracycline antibiotic, has shown anti-inflammatory, anti-apoptotic, and neuroprotective effects in many models of cerebral ischemia and neurodegenerative disease. Its high penetration of the blood-brain barrier, good safety profile, and delayed therapeutic window make it an ideal candidate for use in stroke. In animal models, minocycline reduced infarct size and improved neurologic outcome when administered acutely, with similar neuroprotective benefits seen following delayed administration. To date, two early phase clinical trials have shown minocycline to be safe and potentially effective in acute ischemic stroke, alone or in combination with tissue plasminogen activator. A large efficacy clinical trial is now needed to confirm previous studies, allow for subgroup analysis, and pinpoint the potential place for minocycline in acute stroke therapy.Keywords
This publication has 51 references indexed in Scilit:
- Minocycline to Improve Neurologic Outcome in Stroke (MINOS)Stroke, 2010
- US Geographic Distribution of rt-PA Utilization by Hospital for Acute Ischemic StrokeStroke, 2009
- Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic strokeBMC Neuroscience, 2009
- Minocycline and Tissue-Type Plasminogen Activator for StrokeStroke, 2009
- Determinants of the Timing of Symptomatic Treatment in Early Parkinson DiseaseArchives of Neurology, 2009
- Sex Differences in Minocycline-Induced Neuroprotection after Experimental StrokeJournal of Cerebral Blood Flow & Metabolism, 2009
- Minocycline and neurodegenerative diseasesBehavioural Brain Research, 2009
- Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrationsProceedings of the National Academy of Sciences of the United States of America, 2006
- Use of a Global Test for Multiple Outcomes in Stroke Trials With Application to the National Institute of Neurological Disorders and Stroke t-PA Stroke TrialStroke, 1996
- Clinical Pharmacokinetics of Doxycycline and MinocyclineClinical Pharmacokinetics, 1988